bioMérieux
Nicole Monroe is a Clinical Research Scientist II at bioMérieux since March 2022, having previously served as a Clinical Affairs Scientist II and I at BioFire Diagnostics, LLC from July 2018 to March 2022, where studies for regulatory clearance of infectious disease molecular diagnostic devices were led. Prior experience includes working as an R&D Scientist at ARUP Laboratories, focusing on next-generation sequencing (NGS) panel development, and a Postdoctoral Fellow at the University of Utah School of Medicine, where the mechanism of substrate translocation by Vps4 AAA ATPase was researched. Nicole also instructed Biological Chemistry Lab courses at the University of Utah College of Science. Educational qualifications include a Dr. sc. nat. in Molecular Life Sciences from the University of Zurich and both a Master of Science and Bachelor of Science in Molecular Biotechnology from the Technical University of Munich.
This person is not in any teams
This person is not in any offices
bioMérieux
20 followers
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.